Dr. Quandt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2350Fax+1 415-353-2765
Summary
- I am board certified in Internal Medicine and Endocrinology. My practice combines clinical care and research with a focus on patients who develop endocrine side effects from cancer therapies.
Education & Training
- University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 2016 - 2019
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2013 - 2016
- University of California San Francisco School of MedicineClass of 2013, MD
Certifications & Licensure
- CA State Medical License 2014 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 361 citationsCollateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint InhibitorsAngeliki M. Stamatouli, Zoe Quandt, Ana Luisa Perdigoto, Pamela Clark, Harriet M. Kluger
Diabetes. 2018-08-01 - 95 citationsImmune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes.Zoe Quandt, Arabella Young, Mark S. Anderson
Clinical and Experimental Immunology. 2020-02-06 - 4 citationsEvaluating Survival After Hospitalization Due to Immune-Related Adverse Events From Checkpoint Inhibitors.Jordyn Silverstein, Francis Wright, Michelle Wang, Arabella Young, Daniel Kim
The Oncologist. 2023-10-03
Journal Articles
- Collateral Damage: Insulin-Dependent Diabetes Induced with Checkpoint InhibitorsRobert Rushakoff, Zoe Quandt, James Lee, Kevan C Herold, Diabetes Care
Press Mentions
- Duping Antibodies with a Decoy, Researchers Aim to Prevent Rejection of Transplanted CellsJanuary 2nd, 2023
- A Lifesaver with a Catch: Powerful New Cancer Drugs Can Trigger Diabetes--and No One Is Certain WhyJune 3rd, 2019
- A Lifesaver with a Catch: Powerful New Cancer Drugs Can Trigger Diabetes — and No One Is Certain WhyMay 29th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: